11/2025

• ESG Spotlight

  Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery

• Portfolio News

  Qiming Venture Partners' Portfolio Company WeRide Completes Dual Primary Listing on Hong Kong Stock Exchange

10/2025

• Portfolio News

  Longwood Biopharmaceuticals Secures Hundreds of Millions in Series B+ Financing to Accelerate Core Pipeline Clinical Research and Global Layout

• Portfolio News

  Qiming Venture Partners Exclusively Leads Makera's Pre-A Round

• Portfolio News

  Qiming Venture Partners' Portfolio Company Yunji Technology Successfully Lists on the Hong Kong Stock Exchange

• Qiming News

  Qiming Venture Partners Newsletter – August 2025

09/2025

• Portfolio News

  Qiming Venture Partners' Portfolio Company Hesai Technology Completes Dual Primary Listing on Hong Kong Stock Exchange

08/2025

• Qiming News

  Qiming Venture Partners Newsletter – July 2025

• Portfolio News

  Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing Co-Led by Qiming Venture Partners

07/2025

• Qiming News

  Qiming Venture Partners Newsletter – June 2025

06/2025

• Portfolio News

  Qiming Venture Partners' Portfolio Company Unisound Successfully Lists on the Hong Kong Stock Exchange

• Qiming News

  Qiming Venture Partners Newsletter – May 2025

04/2025

• Portfolio News

  The Lancet Child & Adolescent Health Publishes Phase 3 Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months

• Portfolio News

  Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved

• Qiming News

  Qiming Venture Partners and Founding Managing Partner Duane Kuang Recognized in the List of the World's Best Investment Institutions in 2024

03/2025

• Portfolio News

  Bloomberg Exclusive Interview with Tony Han, Founder and CEO of WeRide: The Final Winner Will Prevail Through Service Quality

• Portfolio News

  WeRide and Renault Group launch their first autonomous Robobus trial in Spain

• Portfolio News

  Unleashing Swarm Intelligence: UBTECH Pioneers the World's First Multi-Humanoid Robot Collaborative Training in Multi-Task, Multi-Scenario Settings at ZEEKR

• Portfolio News

  CNBC Exclusive Interview with Tony Han, Founder and CEO of WeRide: Autonomous Driving Will "Illuminate" the World Like the Invention of the Light Bulb

• Portfolio News

  Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing Co-led by Qiming Venture Partners 

02/2025

• Portfolio News

  WeRide's Latest Robotaxi GXR to Start First Fully Unmanned Commercial Operations in Beijing

• Qiming News

  Qiming Venture Partners Announces Departure of Managing Partner Nisa Leung

01/2025

• Portfolio News

  Qiming Venture Partners' Portfolio Company HyperStrong Successfully Listed on STAR Market

• Portfolio News

  Iongen Therapeutics Secures Over 100M RMB in Pre-A Financing

12/2024

• Qiming News

  Merry Christmas!

• Qiming News

  Qiming Venture Partners' Kan Chen Shares Insights on China's Pharmaceutical Innovations and Investment Outlook in a Globalized Competitive Environment

• Portfolio News

  Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO™ HT Install at Hong Kong Center for Neurodegenerative Diseases

11/2024

• Portfolio News

  MSD Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines

10/2024

• Portfolio News

  The gene therapy for hemophilia B developed by Belief BioMed has received Advanced Therapy Medicinal Product Designation from the EMA

• Portfolio News

  Qiming Venture Partners Celebrates WeRide's IPO on Nasdaq

• Portfolio News

  WeRide Unveils New Production Robotaxi GXR, Leveraging 1,800 Days of Operations

• Portfolio News

  Qiming Venture Partners' Portfolio Company Qiniu Cloud Successfully Lists on HKEX Main Board 

09/2024

• Portfolio News

  Belief BioMed and AskBio, Subsidiary of Bayer, Announced Global Collaboration to Address Unmet Medical Needs with World-Class Gene Therapies

• Portfolio News

  Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI

• Portfolio News

  Hydrogen and hydrogen derivatives-fueled gas turbine company Marvel-Tech completed hundreds of millions of RMB Pre-Series B financing round, led by Qiming Venture Partners

06/2024

• Qiming News

  Qiming's Nisa Leung Made the 2024 Forbes Midas List

05/2024

• Qiming News

  Qiming Venture Partners Promotes Alex Zhou to Managing Partner

04/2024

• Qiming News

  Qiming Monthly Newsletter March 2024

03/2024

• Portfolio News

  Insilico Medicine's Study Published in Nature Biotechnology: First Novel TNIK Inhibitors for Fibrotic Diseases Discovered and Designed Using Generative AI

02/2024

• Qiming News

  Qiming Venture Partners Becomes a UN PRI Signatory

• Qiming News

  Qiming EN Newsletter Jan 2024

01/2024

• Qiming News

  QIMING VENTURE PARTNERS 2024 HEALTHCARE MBA SUMMER INTERNSHIP

• Portfolio News

  SUPERMAG Raises Over RMB 100 Million in Series A Financing

12/2023

• Portfolio News

  Qiming Venture Partners' Portfolio Company UBTech Listed on Hong Kong Stock Exchange

• Portfolio News

  Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck

• Qiming News

  Qiming Monthly Newsletter (November 2023)

11/2023

• Portfolio News

  Clinical Proteomics Startup Complete Omics Inc. Successfully Completes Series A Financing, Exclusively Invested by Qiming Venture Partners

• Qiming News

  Qiming Monthly Newsletter (October 2023)

10/2023

• Qiming News

  Innovation and Technology Venture Fund adds two co-investment partners

• Qiming News

  Qiming Monthly Newsletter (September 2023)

09/2023

• Portfolio News

  Qiming Venture Partners' Portfolio Company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange

• Qiming News

  Qiming Monthly Newsletter (August 2023)

08/2023

• Portfolio News

  Epigenic Therapeutics Announces $32M in Series A Funding

• Qiming News

  Qiming Monthly Newsletter (July 2023)

07/2023

• Qiming News

  Qiming Venture Partners Appoints James Shen as Venture Partner

06/2023

• Qiming News

  Qiming Venture Partners launches first healthcare catalyst program in Hong Kong, empowering future healthcare scientists

• Qiming News

  Qiming Monthly Newsletter (May 2023)

05/2023

• Portfolio News

  LTZ Announces over $10 Million Pre-A+ Financing led by Qiming Venture Partners

• Qiming News

  Qiming Venture Partners Closes RMB Fund VII at RMB6.5 Billion

• Qiming News

  Qiming Monthly Newsletter (April 2023)